BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20717719)

  • 1. RGD-xyloside conjugates prime glycosaminoglycans.
    Tran VM; Victor XV; Yockman JW; Kuberan B
    Glycoconj J; 2010 Aug; 27(6):625-33. PubMed ID: 20717719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Xylosides: Probing the Glycosaminoglycan Biosynthetic Machinery for Biomedical Applications.
    Chua JS; Kuberan B
    Acc Chem Res; 2017 Nov; 50(11):2693-2705. PubMed ID: 29058876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of fluorophore-tagged xylosides that prime glycosaminoglycan chains.
    Tran VM; Kuberan B
    Bioconjug Chem; 2014 Feb; 25(2):262-8. PubMed ID: 24499349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biomedical applications of xylosides.
    Kalita M; Quintero MV; Raman K; Tran VM; Kuberan B
    Methods Mol Biol; 2015; 1229():517-28. PubMed ID: 25325977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and assessment of glycosaminoglycan priming activity of cluster-xylosides for potential use as proteoglycan mimetics.
    Tran VM; Nguyen TK; Sorna V; Loganathan D; Kuberan B
    ACS Chem Biol; 2013 May; 8(5):949-57. PubMed ID: 23402705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the elusive mechanism of glycosaminoglycan biosynthesis.
    Victor XV; Nguyen TK; Ethirajan M; Tran VM; Nguyen KV; Kuberan B
    J Biol Chem; 2009 Sep; 284(38):25842-53. PubMed ID: 19628873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Click'-xylosides as initiators of the biosynthesis of glycosaminoglycans: Comparison of mono-xylosides with xylobiosides.
    Chatron-Colliet A; Brusa C; Bertin-Jung I; Gulberti S; Ramalanjaona N; Fournel-Gigleux S; Brézillon S; Muzard M; Plantier-Royon R; Rémond C; Wegrowski Y
    Chem Biol Drug Des; 2017 Mar; 89(3):319-326. PubMed ID: 27618481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual beta-D-xylosides that prime glycosaminoglycans in animal cells.
    Lugemwa FN; Sarkar AK; Esko JD
    J Biol Chem; 1996 Aug; 271(32):19159-65. PubMed ID: 8702593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biology of oligoethylene glycol linked naphthoxylosides.
    Holmqvist K; Persson A; Johnsson R; Löfgren J; Mani K; Ellervik U
    Bioorg Med Chem; 2013 Jun; 21(11):3310-7. PubMed ID: 23602625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium(II)- and copper(I)-catalyzed synthesis of click-xylosides and assessment of their glycosaminoglycan priming activity.
    Mencio CP; Garud DR; Doi Y; Bi Y; Vankayalapati H; Koketsu M; Kuberan B
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5027-5030. PubMed ID: 29033235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disubstituted naphthyl β-D-xylopyranosides: Synthesis, GAG priming, and histone acetyltransferase (HAT) inhibition.
    Thorsheim K; Persson A; Siegbahn A; Tykesson E; Westergren-Thorsson G; Mani K; Ellervik U
    Glycoconj J; 2016 Apr; 33(2):245-57. PubMed ID: 27023911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New C-Xyloside induces modifications of GAG expression, structure and functional properties.
    Vassal-Stermann E; Duranton A; Black AF; Azadiguian G; Demaude J; Lortat-Jacob H; Breton L; Vivès RR
    PLoS One; 2012; 7(10):e47933. PubMed ID: 23110134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cytoskeletal action of xylosides.
    Mencio CP; Tilve SM; Suzuki M; Higashi K; Katagiri Y; Geller HM
    PLoS One; 2022; 17(6):e0269972. PubMed ID: 35763520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aglycone Ebselen and β-d-Xyloside Primed Glycosaminoglycans Co-contribute to Ebselen β-d-Xyloside-Induced Cytotoxicity.
    Tang Y; Zhang S; Chang Y; Fan D; Agostini A; Zhang L; Jiang T
    J Med Chem; 2018 Apr; 61(7):2937-2948. PubMed ID: 29584939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Screening of α-Xylosides in Human Glioblastoma Cells.
    Kalita M; Villanueva-Meyer J; Ohkawa Y; Kalyanaraman C; Chen K; Mohamed E; Parker MFL; Jacobson MP; Phillips JJ; Evans MJ; Wilson DM
    Mol Pharm; 2021 Jan; 18(1):451-460. PubMed ID: 33315406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of tumor growth by formation of antiproliferative glycosaminoglycans correlates with low acetylation of histone H3.
    Nilsson U; Johnsson R; Fransson LA; Ellervik U; Mani K
    Cancer Res; 2010 May; 70(9):3771-9. PubMed ID: 20406966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-tuning the structure of glycosaminoglycans in living cells using xylosides.
    Persson A; Ellervik U; Mani K
    Glycobiology; 2018 Jul; 28(7):499-511. PubMed ID: 29800297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha- and beta-xylosides alter glycolipid synthesis in human melanoma and Chinese hamster ovary cells.
    Freeze HH; Sampath D; Varki A
    J Biol Chem; 1993 Jan; 268(3):1618-27. PubMed ID: 8420936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of heparan sulfate and chondroitin sulfate proteoglycan biosynthesis.
    Garud DR; Tran VM; Victor XV; Koketsu M; Kuberan B
    J Biol Chem; 2008 Oct; 283(43):28881-7. PubMed ID: 18708345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-deoxy-4-fluoro-xyloside derivatives as inhibitors of glycosaminoglycan biosynthesis.
    Tsuzuki Y; Nguyen TK; Garud DR; Kuberan B; Koketsu M
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7269-73. PubMed ID: 21074423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.